Journal Home
Search for

Articles in Press

Return to articles in press list

Genetic variations in tau-tubulin kinase-1 are linked to Alzheimer's disease in a Spanish case-control cohort

José Luis Vázquez-Higueraa, Ana Martínez-Garcíab, Pascual Sánchez-Juana, Eloy Rodríguez-Rodrígueza, Ignacio Mateoa, Ana Pozuetaa, Ana Frankc, Fernando Valdiviesob, José Bercianoa, María J. Bullidob, Onofre CombarrosaCorresponding Author Informationemail address

Received 10 July 2009; received in revised form 16 December 2009; accepted 24 December 2009. published online 25 January 2010.
Corrected Proof

Abstract 

Neurofibrillary tangles, one of the characteristic neuropathological lesions found in Alzheimer's disease (AD) brains, are composed of abnormally hyperphosphorylated tau protein. Tau-tubulin kinase-1 (TTBK1) is a brain-specific protein kinase involved in tau phosphorylation at AD-related sites. We examined genetic variations of TTBK1 by genotyping nine haplotype tagging SNPs (htSNPs) (rs2104142, rs2651206, rs10807287, rs7764257, rs3800294, rs1995300, rs2756173, rs6936397, and rs6458330) in a group of 645 Spanish late-onset AD patients and 738 healthy controls. Using a recessive genetic model, minor allele homozygotes for rs2651206 in intron 1 (OR=0.50, p=0.0003), rs10807287 in intron 5 (OR=0.49, p=0.0002), and rs7764257 in intron 9 (OR=0.57, p=0.023), which are in strong linkage disequilibrium, had a lower risk of developing AD than subjects homozygotes and heterozygotes for the major allele. TTBK1 is a promising new candidate tau phosphorylation-related gene for AD risk.

a Neurology Service and CIBERNED, “Marqués de Valdecilla” University Hospital (University of Cantabria), Avda. Valdecilla, 39008 Santander, Spain

b Molecular Biology Department and CIBERNED, Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Madrid, Spain

c Neurology Service and CIBERNED, Hospital Universitario La Paz (U.A.M.), Madrid, Spain

Corresponding Author InformationCorresponding author. Tel.: +34 942 202507; fax: +34 942 202655.

PII: S0197-4580(10)00006-0

doi:10.1016/j.neurobiolaging.2009.12.021